APAC
How can Asia-Pacific prove medical research is worth the money?
How can Asia-Pacific prove medical research is worth the money?
Study finds inconsistent methods can distort funding decisions.
1 hour ago
APAC turns to AI as healthcare worker shortfall nears 11 million
Medical inflation nearing 12% in 2025 pushes hospitals toward digital tools.
4 days ago
Medical inflation rises to 11.3% as employers face cost squeeze
One-third of regional markets posted lower healthcare price trends.
6 days ago
How far can institutional capital shape digital health innovation?
Scale increasingly depends less on venture capital backing.
AI moves from pilot phase to core pharma operations
Clinical trials and recruitment are key AI growth areas.
Surgical devices market to surpass $287b by 2031 amidst AI, robotics growth
Increasing use of imaging, analytics, and remote surgical support
Diffusion to confusion: Solving APAC’s healthcare coordination crisis
Fragmented care has left patients facing inconsistent advice and complex journeys.
Precision therapies reshape neurology, immunology markets
Monoclonal antibodies are the most impactful modality.
Biopharma confidence hits four-year high as firms restructure, invest in R&D
M&A deals' value rose 71% YoY in Q1.
AI adoption drives clinical decision support market to $10.15b
Rising chronic diseases, clinical errors, and clinician burnout boosting demand.
One in five APAC doctors eye exit as healthcare demand outpaces workforce
Bain found excessive workload and lack of recognition are driving attrition risk.
Asia Pacific to lead surgical robots growth through 2034, Polaris says
The region leads growth as global market heads toward $55.74b by 2034.
How decentralised clinical trials can unlock Asia's research potential
For many patients across Asia, trial access has hinged on proximity, and not eligibility.
Hospital networks to drive 6.8% annual growth in digital medical partnerships
Asia Pacific is expanding through public health digitisation, amongst others.
AI in healthcare market targets massive growth as data volumes surge
Asia Pacific is expected to witness the fastest growth.
Cancer treatment demand to push radiotherapy market close to $11b by 2031
Asia Pacific to record the fastest growth.
Rising demand for rapid diagnostics drives cardiac marker market toward $9.6b
Point-of-care testing is expected to be the fastest-growing segment.
Most Read
1. Singapore’s AI tool analyses heart attack damage within one minute 2. Sankara Eye Hospital-CUHK deal expands paediatric eye care focus 3. Medical inflation rises to 11.3% as employers face cost squeeze 4. St. Paul's Hospital cuts boiler emissions in HK with Shell renewable diesel blend 5. APAC turns to AI as healthcare worker shortfall nears 11 millionResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention